Clinical trials
Phase 1/2 Carcinoma, Renal Cell trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Argos Therapeutics | 2 |
| Merck Sharp & Dohme LLC | 2 |
| 23andMe, Inc. | 1 |
| AHS Cancer Control Alberta | 1 |
| GlaxoSmithKline | 1 |
| MedImmune LLC | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Mural Oncology, Inc | 1 |
| Nektar Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 18 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Melanoma | 6 |
| Kidney Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Carcinoma, Transitional Cell | 4 |
| Ovarian Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Fallopian Tube Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.